Author:
Mendonça Andréa A.S.,Gonçalves-Santos Elda,Souza-Silva Thaiany G.,González-Lozano Kelly J.,Caldas Ivo S.,Gonçalves Reggiani V.,Diniz Lívia F.,Novaes Rômulo D.
Funder
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference73 articles.
1. Arginase-1 Is responsible for IL-13-mediated susceptibility to Trypanosoma cruzi infection;Abad Dar;Front. Immunol.,2018
2. Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi;Aleixo;BMC Res. Notes.,2012
3. The unsolved jigsaw puzzle of the immune response in Chagas disease;Acevedo;Front. Immunol.,2018
4. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention;Andrade;Nat. Rev. Microbiol.,2005
5. Bahia MT, de Andrade IM, Martins TA, do Nascimento ÁF, Diniz Lde F, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I. Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Negl. Trop. Dis. 2012: 6(11): e1870.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献